Copyright Reports & Markets. All rights reserved.

Global Injectable Targeted Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Monoclonal Antibodies
    • 1.2.3 Small-Molecules
    • 1.2.4 Immunotoxins
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Injectable Targeted Therapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Homecare
    • 1.3.4 Specialty Clinics
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Injectable Targeted Therapy Market Perspective (2015-2026)
  • 2.2 Global Injectable Targeted Therapy Growth Trends by Regions
    • 2.2.1 Injectable Targeted Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Injectable Targeted Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Injectable Targeted Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Injectable Targeted Therapy Players by Market Size
    • 3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
  • 3.4 Global Injectable Targeted Therapy Market Concentration Ratio
    • 3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2019
  • 3.5 Key Players Injectable Targeted Therapy Area Served
  • 3.6 Key Players Injectable Targeted Therapy Product Solution and Service
  • 3.7 Date of Enter into Injectable Targeted Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Targeted Therapy Breakdown Data by Type (2015-2026)

  • 4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2021-2026)

5 Injectable Targeted Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2015-2020)
  • 5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Injectable Targeted Therapy Market Size (2015-2026)
  • 6.2 North America Injectable Targeted Therapy Market Size by Type (2015-2020)
  • 6.3 North America Injectable Targeted Therapy Market Size by Application (2015-2020)
  • 6.4 North America Injectable Targeted Therapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Injectable Targeted Therapy Market Size (2015-2026)
  • 7.2 Europe Injectable Targeted Therapy Market Size by Type (2015-2020)
  • 7.3 Europe Injectable Targeted Therapy Market Size by Application (2015-2020)
  • 7.4 Europe Injectable Targeted Therapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Injectable Targeted Therapy Market Size (2015-2026)
  • 8.2 China Injectable Targeted Therapy Market Size by Type (2015-2020)
  • 8.3 China Injectable Targeted Therapy Market Size by Application (2015-2020)
  • 8.4 China Injectable Targeted Therapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Injectable Targeted Therapy Market Size (2015-2026)
  • 9.2 Japan Injectable Targeted Therapy Market Size by Type (2015-2020)
  • 9.3 Japan Injectable Targeted Therapy Market Size by Application (2015-2020)
  • 9.4 Japan Injectable Targeted Therapy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Injectable Targeted Therapy Market Size (2015-2026)
  • 10.2 Southeast Asia Injectable Targeted Therapy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Injectable Targeted Therapy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Injectable Targeted Therapy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis Injectable Targeted Therapy Introduction
    • 11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2015-2020))
    • 11.1.5 Novartis Recent Development
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Injectable Targeted Therapy Introduction
    • 11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.2.5 Sanofi Recent Development
  • 11.3 GSK
    • 11.3.1 GSK Company Details
    • 11.3.2 GSK Business Overview
    • 11.3.3 GSK Injectable Targeted Therapy Introduction
    • 11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.3.5 GSK Recent Development
  • 11.4 Bayer
    • 11.4.1 Bayer Company Details
    • 11.4.2 Bayer Business Overview
    • 11.4.3 Bayer Injectable Targeted Therapy Introduction
    • 11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.4.5 Bayer Recent Development
  • 11.5 Amgen
    • 11.5.1 Amgen Company Details
    • 11.5.2 Amgen Business Overview
    • 11.5.3 Amgen Injectable Targeted Therapy Introduction
    • 11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.5.5 Amgen Recent Development
  • 11.6 Merck
    • 11.6.1 Merck Company Details
    • 11.6.2 Merck Business Overview
    • 11.6.3 Merck Injectable Targeted Therapy Introduction
    • 11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.6.5 Merck Recent Development
  • 11.7 AbbiVie
    • 11.7.1 AbbiVie Company Details
    • 11.7.2 AbbiVie Business Overview
    • 11.7.3 AbbiVie Injectable Targeted Therapy Introduction
    • 11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.7.5 AbbiVie Recent Development
  • 11.8 AstraZeneca
    • 11.8.1 AstraZeneca Company Details
    • 11.8.2 AstraZeneca Business Overview
    • 11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
    • 11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.8.5 AstraZeneca Recent Development
  • 11.9 Teva
    • 11.9.1 Teva Company Details
    • 11.9.2 Teva Business Overview
    • 11.9.3 Teva Injectable Targeted Therapy Introduction
    • 11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.9.5 Teva Recent Development
  • 11.10 Roche
    • 11.10.1 Roche Company Details
    • 11.10.2 Roche Business Overview
    • 11.10.3 Roche Injectable Targeted Therapy Introduction
    • 11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 11.10.5 Roche Recent Development
  • 11.11 Pfizer
    • 10.11.1 Pfizer Company Details
    • 10.11.2 Pfizer Business Overview
    • 10.11.3 Pfizer Injectable Targeted Therapy Introduction
    • 10.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2015-2020)
    • 10.11.5 Pfizer Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Injectable Targeted Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Targeted Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Monoclonal Antibodies
    Small-Molecules
    Immunotoxins
    Others

    Market segment by Application, split into
    Hospitals
    Homecare
    Specialty Clinics
    Others

    Based on regional and country-level analysis, the Injectable Targeted Therapy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Injectable Targeted Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Novartis
    Sanofi
    GSK
    Bayer
    Amgen
    Merck
    AbbiVie
    AstraZeneca
    Teva
    Roche
    Buy now